Cargando…

Modulation of Protein Stability in Cancer Therapy

This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer. The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Sakamoto, Kathleen (Editor ), Rubin, Eric (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-0-387-69147-3
003 DE-He213
005 20220118181347.0
007 cr nn 008mamaa
008 100301s2009 xxu| s |||| 0|eng d
020 |a 9780387691473  |9 978-0-387-69147-3 
024 7 |a 10.1007/978-0-387-69147-3  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Modulation of Protein Stability in Cancer Therapy  |h [electronic resource] /  |c edited by Kathleen Sakamoto, Eric Rubin. 
250 |a 1st ed. 2009. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2009. 
300 |a X, 165 p. 35 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Ubiquitin Ligases and Cancer -- The 26S Proteasome as a Therapeutic Target in Cancer: Beyond Protease Inhibitors? -- Targeting HAUSP: Killing Two Birds with One Stone -- Modulation of Protein Stability: Targeting the VHL Pathway -- Interrelationship of the Fanconi Anemia/BRCA Pathway -- Targeting the Sumoylation Pathway -- Proteasome Inhibitors -- Targeting Deubiquitinating Enzymes -- Proteolysis Targeting Chimeric Molecules. 
520 |a This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer. The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome. Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed. Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described. 
650 0 |a Cancer. 
650 0 |a Medical microbiology. 
650 0 |a Medical genetics. 
650 0 |a Immunology. 
650 0 |a Biochemistry. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Medical Genetics. 
650 2 4 |a Immunology. 
650 2 4 |a Biochemistry. 
700 1 |a Sakamoto, Kathleen.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Rubin, Eric.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781441924018 
776 0 8 |i Printed edition:  |z 9780387565002 
776 0 8 |i Printed edition:  |z 9780387691435 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-0-387-69147-3  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)